top
Search terms
Results 61 - 70 of 137 - ordered by :
Pages: 1 ... 4 5 6 7 8 9 10 ... 14
Ehjcvp

Unfortunately, gastrointestinal bleeding in patients after acute coronary syndrome portends poor prognosis and is independently associated with increased risk for adverse cardiovascular events and ...

European Heart Journal - Cardiovascular Pharmacotherapy, INVITED EDITORIAL, Muthiah Vaduganathan, Deepak L. Bhatt

Date : 01/01/2016 Item size : 163944 bytes
Ehjcvp

| European Heart Journal - Cardiovascular Pharmacotherapy Erratum to SGLT1 does compensate for SGLT2 inhibition [Eur Heart J Cardiovasc Pharmacother (2016) 2 (4): 256] The reference to Figure 2, ...

European Heart Journal - Cardiovascular Pharmacotherapy, Erratum

Date : 20/10/2016 Item size : 89613 bytes
Ehjcvp

Stroke prevention with oral anticoagulation (OAC) is central to the modern management of atrial fibrillation (AF) patients.1 For many years, vitamin K antagonists (VKAs, e.g. warfarin) have been the ...

European Heart Journal - Cardiovascular Pharmacotherapy, EDITORIALS, Marco Proietti, Gregory Y.H. Lip

Date : 01/07/2015 Item size : 162023 bytes
Ehjcvp

[...]anti-GPIIb/IIIa agents are used in conditions such as acute coronary syndrome undergoing percutaneous intervention where the thrombotic tendency of human body become extremely high.1,2 Since the ...

European Heart Journal - Cardiovascular Pharmacotherapy, EDITORIAL, Shinichi Goto, Shinya Goto

Date : 01/01/2015 Item size : 149314 bytes
Ehjcvp

There are already several scientific journals within clinical cardiology; however, this new journal will have a specified focus on clinical cardiovascular pharmacology. Despite this fast development ...

European Heart Journal - Cardiovascular Pharmacotherapy, EDITORIALS, Stefan Agewall

Date : 01/01/2015 Item size : 98592 bytes
Ehjcvp

Introduction The presence of atrial fibrillation (AF) increases the risk of stroke and thrombo-embolism, and given how common AF is, this represents a considerable healthcare and public health ...

European Heart Journal - Cardiovascular Pharmacotherapy, EDITORIALS, Gregory Y.H. Lip

Date : 01/04/2015 Item size : 213366 bytes
Ehjcvp

Non-steroidal anti-inflammatory drugs (NSAIDs) are commonly used drugs, but much attention has been focused on the relationship of these drugs to cardiovascular conditions.1 In this issue of European ...

European Heart Journal - Cardiovascular Pharmacotherapy, EDITORIALS, Marco Proietti, Gregory Y.H. Lip

Date : 01/04/2015 Item size : 163809 bytes
Ehjcvp

Congestive heart failure (CHF) is a common comorbidity following acute myocardial infarction (AMI), and CHF complicating AMI has an unfavourable outcome. Figure 1 Activation of the ...

European Heart Journal - Cardiovascular Pharmacotherapy, INVITED EDITORIAL, Dave L. Dixon, Antonio Abbate

Date : 01/10/2015 Item size : 124686 bytes
Ehjcvp

The evidence underlying the benefit of these medications is robust.1 However, adherence to prescribing medications is a recognized problem2,3 and showing that poor adherence is associated with worse ...

European Heart Journal - Cardiovascular Pharmacotherapy, ORIGINAL ARTICLE, Paolo Ortolani, Stefano Di Bartolomeo, Massimiliano Marino, Fabio Vagnarelli, Paolo Guastaroba, Claudio Rapezzi, Rossana De ...

Date : 01/10/2015 Item size : 222983 bytes
Ehjcvp

Thanks to these investigations, European and American scientific societies have developed guidelines that provide evidence-based recommendations for treating acute and chronic HF,1,2 including ...

European Heart Journal - Cardiovascular Pharmacotherapy, EDITORIAL, Francesco Pelliccia, Giuseppe M.C. Rosano

Date : 01/01/2015 Item size : 131344 bytes